Abstract Recurrence after curative resection of gastrointestinal (GI) cancers is common. Early detection of resectable recurrences may result in a curative resection. In unresectable recurrences, early detection may improve the quality of life by palliation or with the use of newer chemotherapeutic drugs. The guidelines regarding follow-up of patients after curative resection of GI cancers are from the West which is very different from the Indian population in terms of a disease pattern and social milieu. The guidelines which are commonly used are also not strictly followed. We have proposed in this article the protocols which we follow at our centre after curative resection of GI cancer and how these are different from the guidelines proposed by the West.
Introduction
Surgical resection remains the primary treatment modality for most gastrointestinal (GI) cancers with non-metastatic disease. However, post-resection surveillance is important because recurrence rates after surgery are high even if adjuvant radiotherapy and/or chemotherapy are used.
Early diagnosis of recurrence in patients with GI cancers renders them more suitable for further treatment including curative resection. The benefit is greater if these recurrences are asymptomatic. This is especially true for patients with colorectal cancer because repeated extirpation is associated with a good prognosis, and highly effective chemotherapy is also now available. Although there are standard guidelines for post-resection surveillance, these are rarely followed strictly.
The guidelines that have been proposed previously were from western countries where the disease pattern and social milieu are different with the resources also being more plentiful and so may not be applicable to our Indian patient population. For example, the incidence of colorectal polyps is low in India, and therefore repeated proctosigmoidoscopy may not be required for our patients after curative resection of colorectal cancers. In this article, we propose a strategy that might be followed for patients with GI cancers in India after they have undergone surgical resection of their tumour.
Recurrence Patterns
The majority of recurrences develop within the first 2 years after operation. These recurrences can be local (at the tumour bed and anastomotic site) or distant. The most common recurrence sites for the various GI cancers are as follows:
B. Hepatopancreato-biliary (liver, pancreas, gall bladder, bile duct) cancers.
Luminal Cancers

Colorectal Cancer
The incidence of colorectal cancer (CRC) in India is low as compared to the West but is expected to rise in the near future [1] with the change in our eating habits and lifestyles becoming more 'westernized.' Surgery remains the treatment of choice for patients who present with non-metastatic disease. However, even after curative surgery, 5-year survival rates are 70 % or lower, and most patients require adjuvant chemotherapy and/or radiotherapy for stage II/III disease [2] . Intensive post-operative surveillance is now recommended for these patients [3] [4] [5] .
Rationale for Surveillance Patients with recurrence after potentially curative resection may experience high cure rates if the recurrence is localised, and surgery is also curative if the metastatic disease is limited particularly to the liver and lung [6] [7] [8] [9] [10] . In fact, 5-year survival rates of 30-63 % have been reported after resection of lung metastases [6] [7] [8] . A 5-year survival of more than 40 % and a median survival of more than 30 months have been achieved in selected patients after partial liver resection for colorectal metastases [11] . Asymptomatic recurrences identified by post-operative surveillance are more likely to be suitable for curative resection and have high overall survival rates after surgery [10, 12, 13] . In a meta-analysis of 3,283 patients, comparing intensive follow-up with minimal or no follow-up, patients with intensive follow-up had 9 % better survival rates. Asymptomatic recurrences were detected more frequently in patients who underwent intensive surveillance (45 vs 8 %), and these were more likely to be resectable (35 vs 21 %) [13] . However, these data should not preclude surgeons from operating upon symptomatic recurrences which may also be resectable [14] (Fig. 1) .
Is Surveillance Required for Stage I Disease? Post-resection surveillance strategies generally focus on patients with stage II and III disease. Aggressive surveillance protocols are not recommended for stage I disease because index surgery alone was probably curative. However, in the Clinical Outcomes of Surgical Therapy (COST) trial which included patients with stage I (n=265), IIA, IIB, and III disease, secondary analysis revealed that salvage rates with postoperative surveillance of early-stage disease were similar to late-stage disease [15] . The authors in this study concluded that a similar surveillance strategy should be adopted for stage I disease as well.
Which is Better-Intensive/Less Intensive Surveillance Strategy? Most randomised trials have failed to show a survival benefit with intensive post-operative surveillance strategy [16] [17] [18] [19] , although a few have shown results favouring intensive surveillance [20] . Unfortunately, they had some major drawbacks which include (1) the few patients in some reports, (2) their non-optimal design and (3) the inclusion of patients with stage I disease. However, meta-analyses of these randomised trials have shown a significant survival benefit with intensive surveillance compared to non-intensive surveillance [3] [4] [5] 21] . A meta-analysis also showed that intensive post-operative surveillance was cost-effective [22] .
Tests Available Surveillance strategy should include tests which can identify tumour recurrences early. The common site of this after colorectal cancer resection is the liver except for distal rectal cancers in which lung metastases are more common. The surveillance methods should include the following:
1. History and physical examination: Recurrent disease can be identified in only a few patients based on clinical examination alone [10] . In a study of patients with stage II/III colon cancer, routine physical examination failed to identify any resectable recurrence [14] . However, there are clear benefits of a history and physical examination in that it maintains a good doctor-patient relationship and helps in discussing the results of tests and the importance of routine surveillance. 2. Carcino-embryogenic antigen (CEA): The serum CEA is the only laboratory test recommended for surveillance after resection in colorectal cancer and its measurement the most cost-effective test for detecting recurrences [14, 23] . Estimation of CEA in patients with established disease correlates with the disease burden and has a prognostic value. If the CEA levels are high after curative resection, the risk of residual disease is also high with a 70 % sensitivity of detecting disease relapse [24] . However, it must be remembered that approximately 30-40 % of CRC recurrences do not produce CEA. Why CEA levels should be aggressively monitored? Resection of limited metastases in follow-up after colorectal cancer operations results in long-term disease-free survival in up to 40 %. Studies have shown that CEA levels are elevated earlier compared with other detection methods in those patients with recurrent disease [25] .
3.
Complete blood counts (CBC), liver function tests, chest X-ray and faecal occult blood testing: There is no evidence to suggest that routine testing improves detection rates. 4. Computed tomography (CT) scan: The value of routine post-operative CT scans of the abdomen, pelvis and chest has been supported by meta-analysis. In one meta-analysis, survival benefit was found to be maximal if both CEA levels and CT scans were incorporated into the surveillance strategy [4] . In the USA intergroup studies for colon cancer, a CT scan was not included in a routine post-operative surveillance strategy in contrast to two European trials which included CT scans. In the European trials, 40 % of patients underwent potentially curative resections, while in US studies, the figure was only 20 % [10, 14, 26, 27] . 5. Positron emission tomography (PET) scan: Routine PET scanning to detect recurrence is not recommended. PET scanning may reveal early recurrences and some second primary tumours. The main disadvantage, however, is the number of significant false positive and false negative results. However, PET scanning does have a role in a patient with elevated CEA levels and other imaging studies being negative. . She underwent resection of left psoas mass, right ovary, left common iliac artery, interaortocaval and right common iliac artery lymph nodal mass and aorto-iliac reconstruction using PTFE graft. One month later, her PET-CT showed FDG avid nodular mass in the left psoas muscle (c) for which local resection was done. She is well on follow-up and shows the benefits of aggressive surveillance and treatment strategies for carcinoma of the colon colonic cancer), it should be performed within 6 months post-operatively to diagnose synchronous lesions. Postoperative endoscopic surveillance may detect anastomotic recurrences and metachronous lesions; most of which develop within the first 2-3 years after surgery. Colonoscopy surveillance is required only for 5 years after primary resection, unless some abnormality is detected during standard surveillance [28]. 7. Proctosigmoidoscopy: This has a role in patients with rectal cancer since they have a higher likelihood of anastomotic recurrence. It is also less expensive and safer than a full colonoscopy.
Treatment of Recurrence The treatment of recurrence is summarised in the flow chart (Figs. 2 and 3).
Rationale for Modifications in National Comprehensive Cancer Network Guidelines [29] The National Comprehensive Cancer Network (NCCN) guidelines have been suggested according to the western population which may not be applicable to our Indian population. We therefore have modified the NCCN guidelines and proposed the guidelines as suited to our patient population while keeping in mind not to miss any resectable recurrences (Table 1) . We follow these guidelines at our centre during follow-up period after operation. The main reasons for such modifications are the increased cost of vigorous testing, as more than three fourths of our population pay from their own pockets and have no health insurance, and the long distances the people may need to travel to consult their surgeon. In Indian population, the incidence of colonic and rectal polyps is also low as compared to the west, and therefore, routine proctosigmoidoscopy is not recommended.
Stomach Cancer
The most common sites of recurrence are local (anastomotic site/gastric remnant) or in the liver and peritoneum. Aggressive surveillance strategies are usually expensive and unnecessary since these patients have a poor prognosis after relapse. Most of these patients are not candidates for liver resection and even after resection the prognosis remains poor. Lee and colleagues in a study of post-operative surveillance with endoscopy involving 834 patients with early and advanced gastric cancers concluded that routine endoscopy did not improve survival rates [30] . Similar studies involving post-operative surveillance strategies with endoscopy and PET scans have failed to show a survival benefit [31, 32] . We at our centre follow the guidelines written below with only slight modifications to the NCCN guidelines since the treatment of recurrences does not yield major benefits in this group of patients (Table 2) .
Nutritional Counselling The diet should be rich in protein, low in carbohydrate and low in concentrated sweets. It should Fig. 3 Management of a patient with documented metastases after curative resection of colorectal cancer be rich in iron and vitamin B 12 , and oral iron and calcium supplements should be given. Vitamin B 12 injections should be administered monthly when indicated. The patient should consume five to six small meals a day instead of two large ones because of the absence of the stomach.
Treatment of Recurrence Oesophageal Cancer
Most of the recurrences after resection develop within 1 year, and 60 % of these are at distant sites. However, no trials have been done for post-operative surveillance of oesophageal cancer so there are no data to suggest that detection of asymptomatic recurrences improves longevity or quality of life. The modifications suggested to the NCCN guidelines are given in Table 3 .
Upper GI Endoscopy It should be done only if indicated clinically. During the procedure, mucosal surface changes should be assessed, and biopsies if required should be taken Table 1 Guidelines proposed and practised at our centre for colorectal cancer surveillance after a curative resection as compared to NCCN guidelines
NCCN guidelines Proposed guidelines
History and physical examination Every 3-6 months for the first 2 years, every 6 months during 3-5 years and annually thereafter Every 3-6 months for the first year, every 6 months thereafter for 5 years and annually thereafter Serum CEA Every 3-6 months for 2 years and then every 6 months for a total of 5 years Not recommended since it is not routinely available as an office procedure and is unlikely to yield curable recurrences missed by colonoscopy (at least four to six biopsies) from the abnormal mucosal areas and strictures. Endoscopic dilation should be done if anastomotic stenosis is detected. Endoscopic ultrasound (EUS) if performed in conjunction with endoscopy has a high sensitivity. EUS also has therapeutic benefit as it can be used for guided fine-needle aspiration if suspicious lymph nodes or areas of wall thickening are seen.
Nutritional Counselling It includes detecting nutritional deficiencies and treat them accordingly. The patient should consume soft diet and chew food properly before swallowing and should stay upright for 1-3 h after eating. Liquids should be avoided at meals. He or she should consume frequent small meals instead of two large meals. Treatment of recurrence is shown in Fig. 4 .
Hepatopancreato-Biliary Cancers
Hepatocellular Cancer
Hepatocellular cancer is an aggressive tumour. Underlying cirrhosis is present in >90 % of patients, and most of these are chronic hepatitis B and/or hepatitis C virus positive. The majority of recurrences after resection are intrahepatic (>80 %) and occur within 2 years [33] . Post-operative surveillance is required because of the following:
1. High risk of developing recurrence and progression to liver failure after resection 2. Underlying chronic liver disease provides a field for the development of second primary tumours 3. Underlying chronic liver disease requires regular monitoring and assessment of hepatic reserve.
We follow the same guidelines as laid by the NCCN [29] :
& Imaging: Every 3-6 months for 2 years and then every 6-12 months. & AFP levels: If initially elevated, every 3-6 months for 2 years and then every 6-12 months.
Treatment If intrahepatic recurrence, the treatment options include repeat hepatectomy, radiofrequency ablation, transarterial chemo-embolisation and liver transplantation (Fig. 5) , and if extrahepatic recurrence, systemic therapy. Table 2 Guidelines proposed and practised at our centre for stomach cancer surveillance after a curative resection as compared to NCCN guidelines NCCN guidelines [29] Proposed guidelines History and physical examination Every 3-6 months for 2 years, every 6-12 months for 3-5 years and then annually Every 3-6 months for 1 year and annually thereafter Complete blood counts and other blood chemistry
As clinically indicated Every 3-6 months for 1 year and annually thereafter and as clinically indicated Radiologic imaging
As clinically indicated As clinically indicated Endoscopy As clinically indicated Only if clinically indicated Nutritional counselling
Monitor for nutritional deficiency and treat as indicated Same as NCCN Table 3 Guidelines proposed and practised at our centre for oesophageal cancer surveillance after a curative resection as compared to NCCN guidelines NCCN guidelines [29] Proposed guidelines History and physical examination Every 3-6 months for 2 years, every 6-12 months for 3-5 years and then annually Every 3-6 months for 1 year and then annually CBC and other chemistry profile
As clinically indicated Every 3-6 months for 1 year and then annually Radiologic imaging As clinically indicated As clinically indicated Upper GI endoscopy As clinically indicated Only if clinically indicated Nutritional counselling
Monitor for nutritional deficiencies and modify eating habits
Gall Bladder Cancer
Recurrence after gall bladder resection is mainly locoregional. Port site recurrences have been documented in patients undergoing laparoscopic cholecystectomy in incidentally found gall bladder cancer. We follow the same guidelines as laid by the NCCN [29] :
& Imaging every 6 months for 2 years & No data to support aggressive surveillance.
Treatment of recurrence is shown in Fig. 6 .
Cholangiocarcinoma
The guidelines followed after resection, and the treatment of recurrence is the same as gall bladder cancer.
Pancreatic Cancer
The most common sites of recurrence of pancreatic adenocarcinoma after curative resection are local (60-80 %) and hepatic (50-65 %) with the majority occurring within 2 years. Our centres' protocol after Whipple's pancreatoduodenectomy procedure during follow-up is shown in Table 4 . Treatment of recurrence is shown in Fig. 7 .
For other cancers like intrapapillary mucinous neoplasms (IPMNs, gastrointestinal stromal tumours, carcinoids and other neuroendocrine tumours, we follow the international consensus guidelines.
Intrapapillary Mucinous Neoplasms
Risk of recurrence after resection for non-invasive IPMNs is 7 %, and for invasive IPMNs, 25-30 %.
Surveillance Guidelines The following are the international consensus guidelines for surveillance:
-Lesions of <10 mm=CT/magnetic resonance cholangiopancreatography (MRCP) every 12 months -Lesions 10-20 mm=CT/MRCP every 6-12 months -Lesions of >20 mm=CT/MRCP every 3-6 months If no changes in the cyst after 2 years, interval of followup is lengthened (2-3 years).
These patients are at a high risk of developing extrapancreatic malignancies: colon cancer, gastric cancer, breast cancer and prostate cancer. Therefore, regular follow-up is also required in the form of upper gastrointestinal endoscopy, colonoscopy, prostate-specific antigen and mammography. & Proctoscopy at 6-12 months in addition to the above tests.
Gastrointestinal Stromal Tumours
d. For gastric carcinoids with increased gastrin levels:
& Oesophagogastroduodenoscopy every 6-12 months for the first 3 years.
In summary, definitive surveillance protocols for various GI cancers have been recommended, but they should be modified in different regions according to their patient populations and the diagnostic modalities available. Non-com pliance with these protocols is the main reason behind missing resectable recurrences. Early detection of intrahepatic recurrence of HCC may increase the survival rates by resection/-salvage transplantation. Cancers of the oesophagus, stomach, pancreas and gall bladder do not have effective adjuvant chemotherapy and are usually much more advanced at the time of recurrence. Whether routine surveillance in these cancers improves detection rates at the time of recurrence is controversial, but it does result in an improvement in the quality of life by providing better palliative care. With newer and more effective chemotherapeutic drugs and better diagnostic modalities available, patients may also benefit from strict protocols in these GI cancers in the future. The yield of such rigorous protocols is much more for colorectal cancer recurrences as compared to other GI cancers. These protocols should be incorporated in the discharge summaries of the patient so that these can be followed strictly.
